NORML has long opined that patients must have access to cannabis flowers, stating: “Orally administered non-herbal forms of cannabis possess delayed onset and their effects are far less predictable than those of herbal cannabis.
The post Minnesota: Patients’ Access to Herbal Cannabis Products Begins March 1 appeared first on NORML.